Livforsakringsbolaget Skandia’s Stride LRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-28,800
Closed -$4.29M 509
2025
Q3
$4.29M Buy
28,800
+800
+3% +$117K 0.17% 105
2025
Q2
$4.06M Buy
28,000
+4,900
+21% +$709K 0.18% 109
2025
Q1
$2.92M Sell
23,100
-12,900
-36% -$1.63M 0.16% 106
2024
Q4
$3.74M Hold
36,000
0.2% 99
2024
Q3
$3.07M Buy
36,000
+7,100
+25% +$549K 0.17% 112
2024
Q2
$2.04M Buy
28,900
+1,300
+5% +$86.7K 0.17% 111
2024
Q1
$1.74M Buy
27,600
+8,500
+45% +$513K 0.15% 126
2023
Q4
$1.13M Buy
+19,100
New +$1.05M 0.11% 167
2022
Q4
Sell
-15,800
Closed -$664K 589
2022
Q3
$664K Sell
15,800
-2,000
-11% -$80.6K 0.08% 174
2022
Q2
$726K Buy
17,800
+9,200
+107% +$341K 0.06% 194
2022
Q1
$312K Hold
8,600
0.02% 359
2021
Q4
$287K Buy
+8,600
New +$297K 0.02% 408

Other funds holding LRN

Livforsakringsbolaget Skandia's LRN Position: Q4 2025 in Review

Livforsakringsbolaget Skandia sold out of Stride (LRN) in Q4 2025, closing a stake of 28,800 shares — an estimated $4.29M sold.

Livforsakringsbolaget Skandia first reported a position in LRN in Q4 2021 and held it in 12 quarters. The position peaked at $4.29M in Q3 2025. 396 funds tracked by Wall St. Rank hold LRN as of Q4 2025.

  • Livforsakringsbolaget Skandia reported no remaining Stride position as of Q4 2025 after selling out during the quarter.
  • Livforsakringsbolaget Skandia sold 28,800 Stride shares in Q4 2025, an estimated $4.29M.
  • Livforsakringsbolaget Skandia first reported a position in Stride in Q4 2021 and held it in 12 quarters.
  • Livforsakringsbolaget Skandia's Stride position peaked at $4.29M in Q3 2025.
  • 396 funds tracked by Wall St. Rank held Stride as of Q4 2025.

Based on Livforsakringsbolaget Skandia's 13F filing for Q4 2025, filed 11 Feb 2026.